M. H. Q. Ferreira, “Therapeutic action of the evolocumab monoclonal antibody against PCSK9 proteins in LDL cholesterol modulation: systematic review”, Rev. Atenção Saúde, vol. 15, no. 52, pp. 72–77, Aug. 2017, doi: 10.13037/ras.vol15n52.4439.